Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2025-10-29 00:00:00 ET · period of report 2025-10-23 · accession 0001104659-25-103522 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-29 | 2025-10-23+ | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $6.18 | +154.8K | 3.06M | +5% | +$957.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | P | A | 72,836 | $6.28 | 3,136,576 | I By Emerald Hill Ventures SARL SPF. | — | — | (F1) Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF. |
| 2 | Common | Common Stock | 2025-10-23 | P | A | 46,900 | $6.06 | 3,028,706 | I By Emerald Hill Ventures SARL SPF. | — | — | (F1) Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF. |
| 3 | Common | Common Stock | 2025-10-24 | P | A | 35,034 | $6.15 | 3,063,740 | I By Emerald Hill Ventures SARL SPF. | — | — | (F1) Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF. |